# A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

> **NCT07216027** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 200 (estimated)

## Conditions studied

- Atopic Dermatitis
- Eczema, Atopic

## Interventions

- **DRUG:** PF-08049820
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07216027
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2027-08-23
- **Final completion:** 2027-08-23
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07216027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07216027, "A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07216027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*